VIYASH - Viyash Scientific

Viyash Scientific

VIYASH · Pharma > Pharmaceuticals & Drugs · Chairman: Kamal K Sharma · MD: Manish Gupta · Listing date: March 11, 2016 · Employees: 1770 · Bangalore · http://www.sequent.in

Stock Price vs Company Growth

3.3%

2.0%

4.2%

4.8%

25.5%

40.9%

2.3%

all

1.8%

🤔 How to analyze this graph?

Last Traded Price

₹ 213 3.3%

188

239

Company Overview

Sales

2,126 Cr

Growth: 18.0%

Profit after Tax

76.8 Cr

Growth: -7.4%

Mid Cap

9,290 Cr

P/E: 89.7x

Industry P/E: 28.4x

Fundamentals

Sales (Cr)	₹ 2,126
Growth	18.0%
EBITDA	15.5%
P/S	4.4x
Dividend	0.0%
P/E	89.7x
Book Value	₹ 18.5
PEG Ratio	5.0x
ROE	10.4%
P/B	11.5x

Shareholding Pattern

Institutions

Infinity Holdings

5.91 %

Unit Trust Of India Investment Advisory Services Limited A/C Ascent India Fund Iii

3.35 %

Ashoka India Opportunities Fund

1.35 %

Sbi Healthcare Opportunities Fund

1.21 %

Mukul Mahavir Agrawal

1.05 %

Promoters

Ca Harbor Investments

53.02 %

Chayadeep Ventures Llp

0.27 %

Rajitha Gopalakrishnan

0.2 %

Sajitha Pillai

0.15 %

Vineetha Mohanakumar Pillai

0.12 %

Others

Increase Decrease No change

Company Profile Detailed

Sequent Scientific earlier known as P I Drugs & Pharmaceuticals is an integrated pharmaceutical company. Hon'ble High Court of Bombay approved the Scheme of Amalgamation of company with P I Drugs & Pharmaceuticals Ltd.

Belongs to (12 Indices) view more

Investors (91)

sequent....

dilip.sh...

harish.n...

Followers (7)

jose4

joy2

ratnesh2